Raj Manchanda
Direttore Tecnico/Scientifico/R&S presso NEUMORA THERAPEUTICS, INC.
Posizioni attive di Raj Manchanda
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2023 | - |
Storia della carriera di Raj Manchanda
Precedenti posizioni note di Raj Manchanda
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Anokion US, Inc. | Corporate Officer/Principal | 01/05/2019 | 01/07/2023 |
| KORRO BIO, INC. | Corporate Officer/Principal | 01/02/2016 | 01/10/2018 |
Formazione di Raj Manchanda
| Yale University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
| Anokion US, Inc. |
- Borsa valori
- Insiders
- Raj Manchanda
- Esperienza
